Leukemia Research
Volume 26, Issue 11 , Pages 989-992 , November 2002

Passive active prophylaxis against Hepatitis B in children with acute lymphoblastic leukemia

  • Saika Somjee

      Affiliations

    • Department of Medical Oncology, Tata Memorial Hospital, Dr. Ernest Borges Road, Parel, Mumbai 400012, India
    • ,
  • Suresh Pai

      Affiliations

    • Department of Medical Oncology, Tata Memorial Hospital, Dr. Ernest Borges Road, Parel, Mumbai 400012, India
    • ,
  • Purvish Parikh

      Affiliations

    • Department of Medical Oncology, Tata Memorial Hospital, Dr. Ernest Borges Road, Parel, Mumbai 400012, India
    • Corresponding Author InformationCorresponding author. Tel.: +91-22-4146750; fax: +91-22-4146937.
    • ,
  • Shripad Banavali

      Affiliations

    • Department of Medical Oncology, Tata Memorial Hospital, Dr. Ernest Borges Road, Parel, Mumbai 400012, India
    • ,
  • Rohini Kelkar

      Affiliations

    • Department of Pathology, Tata Memorial Hospital, Dr. Ernest Borges Road, Parel, Mumbai 400012, India
    • ,
  • Suresh Advani

      Affiliations

    • Department of Medical Oncology, Tata Memorial Hospital, Dr. Ernest Borges Road, Parel, Mumbai 400012, India

Received 12 November 2001 ,Accepted 19 February 2002.

References 

  1. Choudhury N, Phadke S. Transfusion transmitted disease. Indian J. Pediatr. 2001;68(10):951–958
  2. Marwaha R, Rawat D, Chawla Y, Trehan A. Seroprevalence of Hepatitis B and C viral infections at diagnosis and during the course of treatment in childhood malignancies. Med. Pediatr. Oncol. 2001;37(3):166
  3. Somjee S, Pai S, Kelkar R, Advani S. Hepatitis B vaccination in children with acute lymphoblastic leukemia: results of an intensified immunization schedule. Leuk. Res. 1999;23:365–367
  4. Goyal S, Pai S, Kelkar R, Advani S. Hepatitis B vaccination in acute lymphoblastic leukemia. Leuk. Res. 1998;22(2):199–201
  5. Pilecki O, Wysocki M, Styczynski J, Dorau M, Olczak A, Kurylak A, et al.  Efficacy of passive and active immunization against HBV infection in children with neoplastic diseases. Paediatr. Pol. 1995;70(5):395–399
  6. Kavakli K, Cetingul N, Oztop S. Combined administration of Hepatitis B vaccine and Hepatitis B immunoglobulin in children with cancer. Paediatr. Hematol. Oncol. 1996;13(3):295–298
  7. Advani SH. Acute lymphoblastic leukemia in India: an analysis of prognostic factors using a single treatment regime. Annal. Oncol. 1999;10:167–176
  8. Hall AJ. Hepatitis B vaccination: protection for how long and against what?. BMJ. 1993;307:276
  9. Kurkure P, Bakshi C, Mehta S, Mohandas KM, Advani S. Hepatitis B virus infection in survivors of childhood cancers: challanges in developing countries lacking universal HBV immunization policy. Med. Pediatr. Oncol. 2001;37(3):166
  10. Lofthouse SA, Andrews AE, Elhay MJ, Bowles VM, Meeuseen EN, Nash AD. Cytokines as adjuvants for ruminant vaccines. Int. J. Parasitol. 1996;8/9:835–842
  11. Minuk GY, Bohme CE, Bowen TJ. Passive and active immunization against Hepatitis B virus infection: optimal scheduling in healthy young adults. Clin. Invest. Med. Jun. 1989;12(3):175–180
  12. Meral A, Sevinir B, Gunay U. Efficacy of immunization against Hepatitis B virus infection in children with cancer. Med. Pediatr. Oncol. 2000;35:47–51

PII: S0145-2126(02)00044-9

Leukemia Research
Volume 26, Issue 11 , Pages 989-992 , November 2002

Article Tools